Related references
Note: Only part of the references are listed.A drug-sensitive genetic network masks fungi from the immune system
Robert T. Wheeler et al.
PLOS PATHOGENS (2006)
Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans
Y Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans
B Enjalbert et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients
R Betts et al.
CANCER (2006)
Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement
R Rajendram et al.
CLINICAL INFECTIOUS DISEASES (2005)
Candida glabrata endophthalmitis treated successfully with caspofungin
JC Sarria et al.
CLINICAL INFECTIOUS DISEASES (2005)
Yeast signaling pathways in the oxidative stress response
A Ikner et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins
J Soustre et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Regulation of the osmoregulatory HOG MAPK cascade in yeast
H Saito et al.
JOURNAL OF BIOCHEMISTRY (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2004)
The Hog1 mitogen-activated protein kinase is essential in the oxidative stress response and chlamydospore formation in Candida albicans
R Alonso-Monge et al.
EUKARYOTIC CELL (2003)
In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance
SP Bachmann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Osmotic stress signaling and osmoadaptation in Yeasts
S Hohmann
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2002)
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia
R Petraitiene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The Saccharomyces cerevisiae Sko1p transcription factor mediates HOG pathway-dependent osmotic regulation of a set of genes encoding enzymes implicated in protection from oxidative damage
M Rep et al.
MOLECULAR MICROBIOLOGY (2001)
Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice
GK Abruzzo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p
XT Zhang et al.
MOLECULAR MICROBIOLOGY (2000)
The transcriptional response of Saccharomyces cerevisiae to osmotic shock -: Hot1p and Msn2p/Msn4p are required for the induction of subsets of high osmolarity glycerol pathway-dependent genes
M Rep et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
